Peripartum cardiomyopathy: Current understanding, comprehensive management review and new developments

Postgraduate Medical Journal

Volumn 87, Issue 1023, 2011, Pages 34-39

  Pyatt, Jason R ^a   Dubey, Gopal ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ENALAPRIL; HEPARIN; HYDRALAZINE; IMMUNOGLOBULIN; NITRATE; PENTOXIFYLLINE; PROLACTIN; WARFARIN;

ANTICOAGULATION; CONGESTIVE CARDIOMYOPATHY; DELIVERY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; LABOR; LACTATION; MORBIDITY; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PERIPARTUM CARDIOMYOPATHY; PROGNOSIS; PROTEIN DEGRADATION; PUERPERIUM; RECURRENCE RISK; REST; REVIEW; SAFETY; SODIUM RESTRICTION; SYSTOLIC DYSFUNCTION; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

CARDIOMYOPATHIES; FEMALE; HUMANS; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PUERPERAL DISORDERS;

EID: 78651348868     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.096594     Document Type: Review

References (80)

1. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971;44:964-8.
2. Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985;312:1432-7.
3. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050-5.
4. Cunningham FG, Pritchard JA, Hankins GD, et al. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events? Obstet Gynecol 1986;67:157-68.
5. Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053-61.
6. Melvin KR, Richardson PJ, Olsen EG, et al. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982;307:731-4.
7. Cénac A, Gaultier Y, Devillechabrolle A, et al. Enterovirus infection in peripartum cardiomyopathy. Lancet 1988;2:968-9.
8. Midei MG, DeMent SH, Feldman AM, et al. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-8.
9. Zimmermann O, Kochs M, Zwaka TP, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 2005;104:92-100.
10. Fett JD. Inflammation and virus in dilated cardiomyopathy as indicated by endomyocardial biopsy. Int J Cardiol 2006;112:125-6.
11. Ansari AA, Fett JD, Carraway RE, et al. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002;23:301-24.
12. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy:National Heart, Lung and Blood Institute and Office of rare Diseases. (National Institute of Heart). Workshop recommendations and review. JAMA 2000;283:1183-8.
13. Bozkurt B, Villaneuva FS, Holubkov R, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999;34:177-80.
14. Warraich RS, Sliwa K, Damasceno A, et al. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 2005;150:263-9.
15. Huerta EM, Erice A, Espino RF, et al. Post-partum cardiomyopathy and acute myocarditis. Am Heart J 1985;110:1079-81.
16. Rizeq MN, Rickenbacher PR, Fowler MB, et al. Incidence of myocarditis in peripartum cardiomypathy. Am Heart J 1994;74:474-7.
17. Sliwa K, Fett JD, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-93.
18. Witlin AG, Mable WC, Sibai BM. Peripartum cardiomyopathy:an ominous diagnosis. Am J Obstet Gynaecol 1997;176:182-8.
19. Ludwig P, Fischer E. Peripartum cardiomyopathy. Aust N J Z Obstet Gynaecol 1997;37:156-60.
20. Silva K, Skudicky D, Bergemann A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma level of cytokines and FAS/APO-1. J Am Coll Cardiol 2000;35:701-5.
21. Hilfiker-Kleiner D, Silva K, Drexeler H. Peripartum cardiomyopathy: Recent insight into its pathophysiology. Trends Cardiovasc Med 2008;18:173-9.
22. Corbacho AM, Martinez De La Escalera G, Clapp C. Roles of prolactin and related members of the prolactin/growth lactogen family in angiogenesis. J Endocrinol 2002;173:219-38. (Pubitemid 34552451)
23. Hilfiker-Kleiner D, Kaminski K, Podewki E, et al. A cathepsin derived 16kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589-600.
24. Tabruyn SP, Soelet CM, Rentier-Delrue F, et al. The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappa B. Mol Endocrinol 2003;7:1815-23. (Pubitemid 37072297)
25. De Jong JS, Rietveld K, Van Lochem LT, et al. Rapid left ventricular recovery after carbergoline treatment in a patient with peripartum cardiomyopathy. Eur J Heart Fail 2009;11:220-2.
26. Habedank D, Kuhenle Y, Elgeti T, et al. Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail 2008;10:1149-51.
27. Hilfiker-Kleiner D, Meyer GP, Schieffer E, et al. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromcriptine. J Am Coll Cardiol 2007;50:2354. (Pubitemid 350192108)
28. Phillips SD, Warnes CA. Peripartum cardiomyopathy: current therapeutic perspectives. Curr Treat Options Cardiovasc Med 2004;6:481-8.
29. Veille JC, Zaccaro D. Peripartum cardiomyopathy: summary of an international survey on peripartum cardiomyopathy. Am J Obstet Gynecol 1999;181:315-19. (Pubitemid 29409906)
30. Cénac A, Simonoff M, Moretto P, et al. A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Saharan Africa. Int J Cardiol 1992;36:57-9.
31. Trevitt L. Attitudes and customs in child birth among Hausa women in Zaria City. Savanna 1973;2:223-6.
32. Davidson NM, Trevitt L, Parry EH. Peripartum cardiac failure an explanation for the observed geographic distribution in Nigeria. Bull World Health Organ 1974:51:203-8.
33. Fett JD. Understanding peripartum cardiomyopathy, 2008. Int J Cardiol 2008;130:1-2.
34. Fett JD, Christie LG, Carraway RD. Five years prospective study of incidences and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clinc Proc 2005;80:1602-6.
35. Fett JD, Carraway RD, Dowell DL, et al. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002;186:1005-10.
36. Mielniczuk LM, Williams K, Davis DR. Frequency of peripartum cardiomyopathy. Am J Cardiol 2006;97:1765-8.
37. Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007;100:302-4.
38. Lampert MB, Hibbard J, Weinert L, et al. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 1993;168:493-5. (Pubitemid 23069098)
39. Pierce JA, Price BO, Joyce JW. Familial occurence of postpartal heart failure. Arch Intern Med. 1963;111:651-5.
40. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J 1995;130:860-70.
41. Fett JD, Christie LG, Carraway RD, et al. Unrecognised peripartum cardiomyopathy in Haitian women. Int J Gyanecology Obstetetrics 2005;90:161-6.
42. Toppenberg KS, Hill DA, Miller DP. Safety of radiographic imaging during pregnancy. Am Fam Physician 1999;59:1813-18.
43. Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med 2005;33:S340-6.
44. Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 1997;177:1129-32.
45. Marmursztejn J, Vignaux O, Goffinet F, et al. Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol 2009;137:e63-4.
46. Frederic M, Christophi L, Pascal DG, et al. Characteristic of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Euro Radiol 2008;18:2765-9.
47. Mouquet F, Lions C, de Groote P, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol 2008;18:2765-9.
48. Sliva K, Tibazarwa K, Hilfiker-Kleiner D. Management of peripartum cardiomyopathy. Curr Heart Fail Rep 2008;5:238-44.
49. Task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology. Expert consensus document on the management of the cardiovascular disease during pregnancy. Eur Heart J 2003;24:761-81.
50. Burch GE, McDonald CD, Walsh JJ. The effect of prolonged bed rest on post partal cardiomyopathy. Am Heart J 1971;81:186-201.
51. Van Hoeven KH, Kitsis RN, Katz SD, et al. Peripartum versus idiopathic dilated cardiomyopathy in young women-a comparison of clinical, pathologic and prognostic features. Int J Cardiol 1993;40:57-65.
52. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006;152:509-13.
53. Shotan A, Widerhorn J, Hurst A, et al. Risks ofangiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994;96:451-6. (Pubitemid 24156732)
54. Rathore SS, Wang Y, Krmholz HM. Sex based difference in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-11. (Pubitemid 35239712)
55. Adams KF Jr, Patterson JH, Gattis WA. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: A retrospective analysis. J Am Coll Cardiol 2005;46:497-504.
56. Heider AL, Kuller JA, Strauss RA, et al. Peripartum cardiomyopathy: a review of the literature. Obstet Gynecol Surv 1999;54:5260-340.
57. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995;130:871-6.
58. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30 year population based study. Ann Intern Med 2005;143:697-706.
59. James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-15.
60. Royal College of Obstetricians & Gynaecologists. Reducing the Risk of Thromboembolism During Pregnancy, Birth and the Puerperium. Guideline no. 37. London: RCOG, 2009.
61. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001;103:2254-9. (Pubitemid 32433714)
62. Velickovic IA, Leicht CH. Peripartum cardiomyopathy and cesarean section: report of two cases and literature review. Arch Gynecol Obstet 2004;270:307-10.
63. Zangrillo A, Landoni G, Pappalardo F, et al. Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section. Minerva Anestesiol 2005;71:227-36. (Pubitemid 41557143)
64. Goland S, Modi K, Bitar F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009;15:645-50.
65. Benlolo S, Lefoll C, Katchatouryan V, et al. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg 2004;98:822-4. (Pubitemid 38252683)
66. Aziz TM, Burgess MI, Acladious NN, et al. Heart transplantation for peripartum cardiomyopathy: a report of three cases and a literature review. Cardiovasc Surg 1999;7:565-7.
67. Oosterom L, de Jonge N, Kirkels J, et al. Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy. Neth Heart J 2008;16:426-8.
68. Aravot DJ, Banner NR, Dhalla N, et al. Heart transplantation for peripartum cardiomyopathy. Lancet 1987;2:1024.
69. Whitehead SJ, Berg CJ, Chang J. Pregnancy related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 2003;102:1326-31.
70. Fett JD, Sanon H, Thelisma E, et al. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynecol Obstet 2009;104:125-7.
71. Dorbala S, Brozena S, Zeb S, et al. Risk stratification of the women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiography 2005;18:45-8. (Pubitemid 40051195)
72. Duran N, Gunes H, Duran I, et al. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 2008;101:137-40.
73. Chapa JB, Heiberger HB, Weinert L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005;105:1303-8. (Pubitemid 40734261)
74. Lampbert MB, Weinert L, Hibbard J, et al. Contractile reserve in patient with peripartum cardiomyopathy and recorded left ventricular function. Am J Obstet Gynecol 1997;176:189-95. (Pubitemid 127780770)
75. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71. (Pubitemid 32479908)
76. Patti G, Nasso G, D'Ambrosio A, et al. Myocardial infarction during pregnancy and postpartum: a review. G Ital Cardiol 1999;29:333-8. (Pubitemid 29177385)
77. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 1996;125:751-76. (Pubitemid 126450364)
78. Goland S, Schwarz ER, Siegel RJ, et al. Pregnancy-associated spontaneous coronary artery dissection. Am J Obstet Gynecol 2007;197:e11-13. (Pubitemid 350166264)
79. Hopp L, Weisse AB, Lffy L. Acute Myocardial infarction in a healthy mother using bromocriptine to suppress lactation. Can J Cardiol 1996;12:415-18. (Pubitemid 26140491)
80. Sliwa K, Skudicky D, Candy G, et al. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002;4:305-9. (Pubitemid 35190355)